Pharmaceutical News

RSS

Statin use may reduce risk of developing lethal prostate cancer

New research led by Queen's University Belfast has found that men who are on statins, medicine used to lower blood cholesterol, may have a reduced risk of developing a more lethal form of prostate cancer.

21 Nov 2019

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

The inventors of a new and unique cancer immunotherapy developed at Roswell Park Comprehensive Cancer Center have announced a major step forward with that therapy, known as SurVaxM. MimiVax LLC principals Robert Fenstermaker, MD, and Michael Ciesielski, PhD, have announced that the company, spun off from Roswell Park in 2012, has entered into a China-exclusive licensing agreement for SurVaxM with Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd., a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical Co. Ltd. based in Shanghai, China.

20 Nov 2019

New California law may expand use of HIV prevention drugs, with caveats

Kellen Willhite was 24 when he learned he'd been exposed to HIV. What followed was, as he describes it, a second trauma: trying to obtain the drugs that could save him before it was too late.

20 Nov 2019

New drug 'ubrogepant' may work for migraine

A new study published in the November 19, 2019 issue of JAMA shows that a newly developed small molecule drug called ubrogepant may successfully fight migraine at doses of 25 and 50 mg, with pain relief at 2 hours with both doses, while the most troublesome symptom of migraine was held off at 2 hours post-dose with the 50 mg dose. This may help millions of migraine patients to achieve pain relief and function better.

19 Nov 2019

Improving the efficiency of antiangiogenic and antifibrotic drug for treatment of lung cancer

The University of Barcelona and Hospital Clínic de Barcelona collaborate with Boehringer Ingelheim Inc. to improve the efficiency of nintedanib, an antiangiogenic and antifibrotic drug, for the treatment of lung cancer.

19 Nov 2019

Scientists develop new therapy for acute myeloid leukemia

Cold Spring Harbor Laboratory scientists, with chemists and cancer biologists from Dana-Farber Cancer Institute, have developed a new therapy that extended the survival of mice with acute myeloid leukemia.

19 Nov 2019

Ketamine can decrease alcohol consumption in men, reveal FSU researchers

Research from Florida State University is giving physicians a better understanding of ketamine, a potentially useful tool in treating depression that still has unanswered questions.

19 Nov 2019

Researchers propose a novel method to underscore the benefits of HPV vaccine

Health campaigns on social media aimed at increasing human papillomavirus (HPV) vaccination may see greater success, according to Drexel University researchers, if they inject a narrative into information-based posts.

19 Nov 2019

Cannabis cannot be used as a replacement drug for people with opioid use disorder

There has been interest in cannabis being used as a replacement drug for people with opioid use disorder, but research at McMaster University has found it doesn't work.

19 Nov 2019

Antibiotics face an existential crisis

Antibiotics are facing an existential crisis less than a century after their introduction. The bacteria-fighting drugs are becoming less effective as a result of their overuse in both humans and animals.

18 Nov 2019

New CDC report raises concern over growing threat of antibiotic resistance

In the US, antibiotic-resistant germs are making millions sick and killing tens of thousands, according to new CDC report.

18 Nov 2019

WHO announces two-year scheme to drive down the price of insulin

The World Health Organization plans to make insulin more affordable for the millions of people suffering from diabetes.

18 Nov 2019

Opioid dose tapering rates as much as six times higher than recommended

Stigma and safety fears have made daily dose tapering of opioid prescriptions more common. New research from UC Davis Health physicians, however, shows tapering can occur at rates as much as six times higher than recommended, putting patients at risk of withdrawal, uncontrolled pain or mental health crises.

18 Nov 2019

Study examines how drug promotion rules influence physician prescribing practices

Findings from a new study led by researchers at Dartmouth's Geisel School of Medicine and Harvard Medical School and published in the journal Circulation: Cardiovascular Quality and Outcomes, show that the way in which pharmaceutical companies are permitted to share information about their drugs can influence physician prescribing practices.

14 Nov 2019

FDA grants acceptance to application for selumetinib as treatment for neurofibromatosis

AstraZeneca and MSD (Merck) announced today that the U.S. Food and Drug Administration (FDA) has granted acceptance to file status of its application for the MEK inhibitor selumetinib, for use in patients with plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1).

14 Nov 2019

Regular co-use of pain and sleep medications may increase risk of frailty in older adults

Researchers from the Oregon Research Institute and Florida Atlantic University are the first to demonstrate statistically significant links between self-reported regular use of prescription drugs for pain and/or sleep, and longitudinal risk of frailty in adults ages 65 and older.

13 Nov 2019

New study highlights opportunities to optimize use of PrEP to prevent HIV among sex workers

Preventing HIV in sex workers is a powerful tool in lowering the worldwide burden of the disease, and a new study could help ensure that high-risk women take advantage of medical safeguards.

13 Nov 2019

$Receiving multiple fracture-associated drugs may increase hip fracture risk$

Receiving multiple fracture-associated drugs may increase hip fracture risk

There is a strong association between the number of fracture-associated drugs (FADs) older patients receive and their risk of sustaining a broken bone, according to a new Dartmouth study published in JAMA Network Open.

13 Nov 2019

Researchers develop novel mathematical framework for mapping out drug interaction

Combining two or more drugs can be an effective treatment of diverse diseases, such as cancer. Yet, at the same time, the wrong drug combination can cause major side effects. Currently there is no systematic understanding of how different drugs influence each other. Thus, elucidating how two given drugs interact, and whether they have a beneficial effect, would mean a major step towards drug development to treat diseases more effectively in the future.

13 Nov 2019

Novartis announces strategy to broaden patient reach and availability of medicines in sub-Saharan Africa

Novartis announced today a new strategy to broaden patient reach and availability of its portfolio of medicines in sub-Saharan Africa, which is home to the largest underserved patient population in the world.

13 Nov 2019

Pharmaceutical News

Statin use may reduce risk of developing lethal prostate cancer

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

New California law may expand use of HIV prevention drugs, with caveats

New drug 'ubrogepant' may work for migraine

Improving the efficiency of antiangiogenic and antifibrotic drug for treatment of lung cancer

Scientists develop new therapy for acute myeloid leukemia

Ketamine can decrease alcohol consumption in men, reveal FSU researchers

Researchers propose a novel method to underscore the benefits of HPV vaccine

Cannabis cannot be used as a replacement drug for people with opioid use disorder

Antibiotics face an existential crisis

New CDC report raises concern over growing threat of antibiotic resistance

WHO announces two-year scheme to drive down the price of insulin

Opioid dose tapering rates as much as six times higher than recommended

Study examines how drug promotion rules influence physician prescribing practices

FDA grants acceptance to application for selumetinib as treatment for neurofibromatosis

Regular co-use of pain and sleep medications may increase risk of frailty in older adults

New study highlights opportunities to optimize use of PrEP to prevent HIV among sex workers

Receiving multiple fracture-associated drugs may increase hip fracture risk

Researchers develop novel mathematical framework for mapping out drug interaction

Novartis announces strategy to broaden patient reach and availability of medicines in sub-Saharan Africa

Artificial Intelligence (AI) in Cancer Care

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Applying a Proteomics-based Approach to the Clinic

Latest News